Dendritic cell function during chronic hepatitis C virus and human immunodeficiency virus type 1 infection

Clinical and Vaccine Immunology

Volumn 14, Issue 9, 2007, Pages 1127-1137

  Fan, Zheng ^a   Huang, Xiao Li ^a   Kalinski, Pawel ^a   Young, Stephen ^b   Rinaldo Jr , Charles R ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b TRICORE REFERENCE LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; PROTEIN P70; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ T LYMPHOCYTE; CELL ACTIVITY; CELL FUNCTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LYMPHOCYTE ACTIVATION; MONOCYTE; PRIORITY JOURNAL;

CD40 LIGAND; DENDRITIC CELLS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOTHERAPY; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-1BETA; INTERLEUKINS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34948822417     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00141-07     Document Type: Article

References (54)

1. Anthony, D. D., N. L. Yonkers, A. B. Post, R. Asaad, F. P. Heinzel, M. M. Lederman, P. V. Lehmann, and H. Valdez. 2004. Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection. J. Immunol. 172:4907-4916.
2. Banchereau, J., and A. K. Palucka. 2005. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5:296-306.
3. Barber, L. D., and J. A. Madrigal. 2006. Exploiting beneficial alloreactive T cells. Vox Sang. 91:20-27.
4. Bowen, D. G., and C. M. Walker. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436:946-952.
5. Caliendo, A. M., A. Valsamakis, Y. Zhou, B. Yen-Lieberman, J. Andersen, S. Young, A. Ferreira-Gonzalez, G. J. Tsongalis, R. Pyles, J. W. Bremer, and N. S. Lurain. 2006. Multilaboratory comparison of hepatitis C virus viral load assays. J. Clin. Microbiol. 44:1726-1732.
6. Chougnet, C., S. S. Cohen, T. Kawamura, A. L. Landay, H. A. Kessler, E. Thomas, A. Blauvelt, and G. M. Shearer. 1999. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: implications for immunotherapy. J. Immunol. 163:1666-1673.
7. de Jong, E. C., H. H. Smits, and M. L. Kapsenberg. 2005. Dendritic cell-mediated T cell polarization. Springer Semin. Immunopathol. 26:289-307.
8. Encke, J., J. Findeklee, J. Geib, E. Pfaff, and W. Stremmel. 2005. Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection. Clin. Exp. Immunol. 142:362-369.
9. Garcia, F., M. Lejeune, N. Climent, C. Gil, J. Alcami, V. Morente, L. Alos, A. Ruiz, J. Setoain, E. Fumero, P. Castro, A. Lopez, A. Cruceta, C. Piera, E. Florence, A. Pereira, A. Libois, N. Gonzalez, M. Guila, M. Caballero, F. Lomena, J. Joseph, J. M. Miro, T. Pumarola, M. Plana, J. M. Gatell, and T. Gallart. 2005. Therapeutic immunization with dendritic cells loaded with heat-inactivated autologous HIV-1 in patients with chronic HIV-1 infection. J. Infect. Dis. 191:1680-1685.
10. Gowans, E. J., K. L. Jones, M. Bharadwaj, and D. C. Jackson. 2004. Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. J. Clin. Virol. 30:283-290.
11. Greub, G., B. Ledergerber, M. Battegay, P. Grob, L. Perrin, H. Furrer, P. Burgisser, P. Erb, K. Boggian, J. C. Piffaretti, B. Hirschel, P. Janin, P. Francioli, M. Flepp, and A. Telenti. 2000. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 356:1800-1805.
12. Hilkens, C. M., P. Kalinski, M. de Boer, and M. L. Kapsenberg. 1997. Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype. Blood 90:1920-1926.
13. Huang, X. L., Z. Fan, B. A. Colleton, R. Buchli, H. Li, W. H. Hildebrand, and C. R. Rinaldo, Jr. 2005. Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons. J. Virol. 79:3052-3062.
14. Hwu, P., M. X. Du, R. Lapointe, M. Do, M. W. Taylor, and H. A. Young. 2000. Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J. Immunol. 164:3596-3599.
15. Kakimi, K. 2003. Immune-based novel therapies for chronic hepatitis C virus infection. Hum. Cell 16:191-197.
16. Kalinski, P., J. H. Schuitemaker, C. M. Hilkens, E. A. Wierenga, and M. L. Kapsenberg. 1999. Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. J. Immunol. 162:3231-3236.
17. Kanto, T., and N. Hayashi. 2006. Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity. Intern. Med. 45:183-191.
18. Kanto, T., M. Inoue, H. Miyatake, A. Sato, M. Sakakibara, T. Yakushijin, C. Oki, I. Itose, N. Hiramatsu, T. Takehara, A. Kasahara, and N. Hayashi. 2004. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection. J. Infect. Dis. 190:1919-1926.
19. Kuzushita, N., S. H. Gregory, N. A. Monti, R. Carlson, S. Gehring, and J. R. Wands. 2006. Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens. Gastroenterology 130:453-464.
20. Langenkamp, A., M. Messi, A. Lanzavecchia, and F. Sallusto. 2000. Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells. Nat. Immunol. 1:311-316.
21. Larsson, M. 2006. The dendritic cell: the immune system's adjuvant - a strategy to develop a HCV vaccine? Gastroenterology 130:603-606.
22. Longman, R. S., A. H. Talal, I. M. Jacobson, M. L. Albert, and C. M. Rice. 2004. Presence of functional dendritic cells in patients chronically infected with hepatitis C virus. Blood 103:1026-1029.
23. Lori, F., L. M. Kelly, and J. Lisziewicz. 2004. APC-targeted immunization for the treatment of HIV-1. Expert Rev. Vaccines 3:S189-S198.
24. Lu, W., L. C. Arraes, W. T. Ferreira, and J. M. Andrieu. 2004. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat. Med. 10:1359-1365.
25. Mailliard, R. B., A. Wankowicz-Kalinska, Q. Cai, A. Wesa, C. M. Hilkens, M. L. Kapsenberg, J. M. Kirkwood, W. J. Storkus, and P. Kalinski. 2004. Alpha-type-1 polarized dendritic cells: a novel immunization tool with optimized CTL-inducing activity. Cancer Res. 64:5934-5937.
26. Martins, S. L., L. S. St John, R. E. Champlin, E. D. Wieder, J. McMannis, J. J. Molldrem, and K. V. Komanduri. 2004. Functional assessment and specific depletion of alloreactive human T cells using flow cytometry. Blood 104:3429-3436.
27. McHutchison, J. G., G. Giannelli, L. Nyberg, L. M. Blatt, K. Waite, P. Mischkot, S. Pianko, A Conrad, and P. Grint. 1999. A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection. J. Interferon Cytokine Res. 19:1265-1270.
28. McIlroy, D., and M. Gregoire. 2003. Optimizing dendritic cell-based anticancer immunotherapy: maturation state does have clinical impact. Cancer Immunol. Immunother. 52:583-591.
29. Mege, J. L., S. Meghari, A. Honstettre, C. Capo, and D. Raoult. 2006. The two faces of interleukin 10 in human infectious diseases. Lancet Infect. Dis. 6:557-569.
30. Murakami, H., S. M. Akbar, H. Matsui, N. Horiike, and M. Onji. 2004. Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C. Clin. Exp. Immunol. 137:559-565.
31. Napolitani, G., A. Rinaldi, F. Bertoni, F. Sallusto, and A. Lanzavecchia. 2005. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat. Immunol. 6:769-776.
32. Nelson, D. R., Z. Tu, C. Soldevila-Pico, M. Abdelmalek, H. Zhu, Y. L. Xu, R. Cabrera, C., Liu, and G. L. Davis. 2003. Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect. Hepatology 38:859-868.
33. Newton, P. J., I. V. Weller, I. G. Williams, R. F. Miller, A. Copas, R. S. Tedder, D. R. Katz, and B. M. Chain. 2006. Monocyte derived dendritic cells from HIV-1 infected individuals partially reconstitute CD4 T-cell responses. AIDS 20:171-180.
34. O'Sullivan, B., and R. Thomas. 2003. CD40 and dendritic cell function. Crit. Rev. Immunol. 23:83-107.
35. Piccioli, D., S. Tavarini, S. Nuti, P. Colombatto, M. Brunetto, F. Bonino, P. Ciccorossi, F. Zorat, G. Pozzato, C. Comar, S. Abrignani, and A. Wack. 2005. Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors. J. Hepatol. 42:61-67.
36. Pulendran, B. 2006. Division of labor and cooperation between dendritic cells. Nat. Immunol. 7:699-700.
37. Rehermann, B., and M. Nascimbeni. 2005. Immunology of hepatitis B virus and hepatitis C virus infection. Nat. Rev. Immunol. 5:215-229.
38. Rigopoulou, E. I., W. G. Abbott, P. Haigh, and N. V. Naoumov. 2005. Blocking of interleukin-10 receptor - a novel approach to stimulate T-helper cell type 1 responses to hepatitis C virus. Clin. Immunol. 117:57-64.
39. + T cells by dendritic cells expressing hepatitis C virus core and E1 proteins. J. Virol. 76:5062-5070.
40. Schiller, M., M. Metze, T. A. Lugar, S. Grabbe, and M. Gunzer. 2006. Immune response modifiers - mode of action. Exp. Dermatol. 15:331-341.
41. Shepard, C. W., L. Finelli, and M. J. Alter. 2005. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5:558-567.
42. Sherman, L. A., and S. Chattopadhyay. 1993. The molecular basis of allorecognition. Annu. Rev. Immunol. 11:385-402.
43. Snijders, A., C. M. Hilkens, T. C. van der Pouw Kraan, M. Engel, L. A. Aarden, and M. L. Kapsenberg. 1996. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156:1207-1212.
44. Snijders, A., P. Kalinski, C. M. Hilkens, and M. L. Kapsenberg. 1998. High-level IL-12 production by human dendritic cells requires two signals. Int. Immunol. 10:1593-1598.
45. Stebbing, J., S. Patterson, S. Portsmouth, C. Thomas, R. Glassman, A. Wildfire, F. Gotch, M. Bower, M. Nelson, and B. Gazzard. 2004. Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patients. Cell Res. 14:251-256.
46. Steinman, R. M. 2003. Some interfaces of dendritic cell biology. APMIS 111:675-697.
47. Tan, Y. J., S. G. Lim, and W. Hong. 2006. Understanding human immunodeficiency virus type 1 and hepatitis C virus coinfection. Curr. HIV Res. 4:21-30.
48. Reference deleted.
49. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146.
50. Vieira, P. L., E. C. de Jong, E. A. Wierenga, M. L. Kapsenberg, and P. Kalinski. 2000. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction. J. Immunol. 164:4507-4512.
51. Wang, Q. C., Z. H. Feng, Y. X. Zhou, and Q. H. Nie. 2005. Induction of hepatitis C virus-specific cytotoxic T and B cell responses by dendritic cells expressing a modified antigen targeting receptor. World J. Gastroenterol. 11:557-560.
52. Wertheimer, A. M., A. Bakke, and H. R. Rosen. 2004. Direct enumeration and functional assessment of circulating dendritic cells in patients with liver disease. Hepatology 40:335-345.
53. Xiang, M., C. Eisenbach, C. M. Lupu, E. Ernst, W. Stremmel, and J. Encke. 2006. Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3. Viral Immunol. 19:210-219.
54. Yu, H., H. Huang, J. Xiang, L. A. Babiuk, and S. van Drunen Littel-van den Hurk. 2006. Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3. J. Gen. Virol. 87:1-10.